MSF Access

21/05/2026

This week, we are right here at the World Health Assembly ( ), calling for countries to make sure global health policies for the coming years ensure everyone, everywhere has access to affordable medical products.

Read the statements 👉 https://msfaccess.org/msf-statements-who-world-health-assembly-79th-session

20/05/2026

During the 79th World Health Assembly this week, MSF representatives will address critical health issues at the World Health Assembly this week, calling for urgent action on:

🦠Antimicrobial resistance
🩺Noncommunicable diseases
😷Pandemic preparedness & response
💉Vaccines

Read the statements here:

MSF statements on access to healthcare products at 79th World Health Assembly

19/05/2026

📢This World Health Assembly , we’re calling for countries, donors, and other global health stakeholders to urgently dismantle the barriers blocking access to lifesaving vaccination in conflict-affected settings by:

📌Removing administrative and bureaucratic blockages and strengthening collaboration between health authorities, humanitarian partners, and communities to ensure timely and unhindered access to vaccine supplies and hard-to-reach areas.

📌Ensuring flexible and adapted delivery models to reach children in conflict settings and stop delays in people’s access to lifesaving vaccines.

📌Dedicating sustained and agile financing to ensure immunisation activities reach people in the world’s most fragile areas.

Sustained funding, timely and unhindered access to vaccine supplies, and flexible, secure and adapted delivery models required to reach more people with lifesaving vaccination in world’s most fragile areas

18/05/2026

15/05/2026

Did you know that the Pandemic Agreement, signed one year ago, is still on hold because of an annex? Enter the PABS annex!

Without the Pathogen Access and Benefit Sharing (PABS) annex, countries cannot ratify or implement the Pandemic Agreement, but major disagreements remain unresolved. Governments must advance negotiations toward a strong multilateral PABS framework to ensure access is based on enforceable benefit‑sharing.

“For decades, MSF has witnessed communities in resource-limited settings affected by deadly outbreaks, including Ebola and more recently COVID-19, often receive no or severely delayed access to lifesaving medical tools. Communities who share critical samples and data, and those most at risk during outbreaks and health emergencies cannot anymore be the last to benefit from medical innovation,” highlighted Dr Maria Guevara, MSF International Medical Secretary. “We strongly urge governments to act now.”

MSF calls on countries to prepare for early implementation of the Pandemic Agreement.

08/05/2026

We address antimicrobial resistance through dedicated prevention, detection, and response efforts in over twenty countries and across fifty projects. Like in this one In the Central African Republic ( ), where we support patients infected with antibiotic-resistant bacteria.

Thanks to the microbiology laboratory integrated into the SICA hospital in Bangui, CAR, profiles are identified and patients can be treated effectively.

30/04/2026

Vaccines are one of the most successful and widespread public health tools used to protect against disease, but they’re not always affordable, adapted to context, or accessible to everyone who needs them. And, in some cases, there are simply no vaccines available yet to protect against certain diseases.

With 14.3 million children having missed out on receiving any vaccination in 2024, it’s time to close the gap in vaccine access.

This World Immunisation Week and beyond, MSF teams in Pakistan, France, South Sudan, Nigeria, and Sudan share access and innovation advancements that, if achieved in the years to come, could result in lifesaving vaccines reaching more people around the world.

This World Immunisation Week and beyond, MSF teams in Pakistan, France, South Sudan, Nigeria, and Sudan share access and innovation advancements that, if achieved in the years to come, could result in lifesaving vaccines reaching more people around the world.

30/04/2026

In 2024, half of the 14.3 million children who missed out on receiving any vaccination lived in countries affected by conflict, fragility, or humanitarian crises. It's time to close this gap through timely access to vaccines for all children, everywhere.

29/04/2026

Neglected diseases are estimated to affect more than 1 billion people. However, there's limited attention and funding into vaccine research & development for these diseases. Safe & effective vaccines would be impactful in reducing the burden of neglected diseases.

Carolina Nanclares, medical coordinator for MSF, currently in Nigeria, on neglected diseases, particularly Lassa fever.

28/04/2026

Each year, over a quarter of a million children acquire chronic hepatitis B at birth, resulting in many premature deaths.

If every newborn received hepatitis B birth dose – an affordable vaccine supported by Gavi – these deaths could be prevented.